Viewing Study NCT04789564



Ignite Creation Date: 2024-05-06 @ 3:51 PM
Last Modification Date: 2024-10-26 @ 1:59 PM
Study NCT ID: NCT04789564
Status: COMPLETED
Last Update Posted: 2022-04-11
First Post: 2021-03-05

Brief Title: Predictive Value of Cardiovascular Magnetic Resonance Related Parameters in STEMI Patients After Primary PCI for Adverse Left Ventricular Remodeling and Major Adverse Cardiovascular Events
Sponsor: Qian geng
Organization: Chinese PLA General Hospital

Study Overview

Official Title: Predictors of Cardiovascular Magnetic Resonancerelated Parameters Intramyocardial Hemorrhage Microvascular Obstruction Area at Risk and Strain Related Parameters and Their Effects on Adverse Ventricular Remodeling and MACEs in STEMI Patients After Primary PCI
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aim to investigate the predictive value of CMR parameters infarct size IS intramyocardial hemorrhage microvascular obstruction area at risk and CMR derived strain parameters with the Major Adverse Cardiovascular Events MACEs and myocardial remodeling afterinfarction
Detailed Description: Investigators will enroll 500 patients with STEMI after PCI who were admitted to the Chinese PLA General Hospital and other eight hospitals across China Wuhan Asia Heart Hospital the First Peoples Hospital of Yunlin Chaoyang Hospital Capital Medical University Hainan Hospital of PLA General Hospital the Second Affiliated Hospital of Nanchang University the Second Hospital of Hebei Medical University Guizhou Provincial Peoples Hospital Affiliated Hospital of Zunyi Medical College between January 2014 and December 2019 CMR was performed at 7 days and 6 months after primary PCI to assess the final infarction sizeIS microvascular obstruction MVO intramyocardial hemorrhageIMH area at risk AAR and related strain parameters All patients will be followed up by 5 years after adimission Cardiovascular events concluded stroke repeat revascularization rehospitalization for acute heart failure nonfatal myocardial infarction and all cause death All adverse clinical events as well as study end points were monitored and adjudicated by the independent event committee

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None